Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A novel combination treatment against melanoma with NRAS mutation and therapy resistance.

EMBO molecular medicine - 1 May 2018

Yu Yanlin

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to NRAS gene
Share to GTP Phosphohydrolases
Share to Melanoma
Share to Membrane Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Salvage Therapy

Source

Open in PubMed Open full text

Identifiers

PMID: 29661909
DOI: 10.15252/emmm.201708573
PMCID: PMC5938621

Genes

NRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A novel combination treatment against melanoma with NRAS mutation and therapy resistance.PMID 29661909Read ↗

Targeting NRAS Mutations in Advanced Melanoma.Semantic proximity Read ↗

Beyond BRAF: where next for melanoma therapy?Semantic proximity Read ↗

Targeted Therapy Innovations for Melanoma.Semantic proximity Read ↗

NRAS mutant melanoma: Towards better therapies.Semantic proximity Read ↗

Advances in Understanding Drug Resistance Mechanisms and Innovative Clinical Treatments for Melanoma.Semantic proximity Read ↗

A step forward for patients with NRAS-mutant melanoma.Semantic proximity Read ↗

Association of NRAS Mutation With Clinical Outcomes of Anti-PD-1 Monotherapy in Advanced Melanoma: A Pooled Analysis of Four Asian Clinical Trials.Semantic proximity Read ↗

BRAF inhibitors: resistance and the promise of combination treatments for melanomaSemantic proximity Read ↗

Targeted therapeutic strategies for melanoma.Semantic proximity Read ↗

NRAS-mutant melanoma: response to chemotherapy.Semantic proximity Read ↗

Targeting the MAPK pathway for NRAS mutant melanoma: from mechanism to clinic.Semantic proximity Read ↗

Outcome of combination therapy using BRAF and MEK inhibitors among Asian patients with advanced melanoma: An analysis of 112 casesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.